Dagmar Pospíšilová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dagmar Pospíšilová has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Barbora Ludíková
Department of Pediatrics, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacký University, Olomouc, Czech Republic
2 shared publications - Petr Birke
Department of Pediatrics, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacký University, Olomouc, Czech Republic
2 shared publications - Dušan Klos
Department of Surgery, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacký University, Olomouc, Czech Republic
1 shared publication - Eva Kriegova
Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
1 shared publication - Hana Flogelova
Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
1 shared publication - Jana Zapletalová
Department of Medical Biophysics, Faculty of Medicine and Dentistry Palacký University, Olomouc, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 25 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Minimally invasive management of pediatric hereditary spherocytosis: severity-stratified biliary risk and indications for simultaneous cholecystectomy and biliary intervention at laparoscopic splenectomy – a single-center retrospective study
Hereditary spherocytosis (HS) is an inherited hemolytic anemia in which splenectomy may be indicated in moderate to severe disease. Chronic hemolysis incre
- 25 July 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessMinimally invasive management of pediatric hereditary spherocytosis: severity-stratified biliary risk and indications for simultaneous cholecystectomy and biliary intervention at laparoscopic splenectomy – a single-center retrospective study
Hereditary spherocytosis (HS) is an inherited hemolytic anemia in which splenectomy may be indicated in moderate to severe disease. Chronic hemolysis incre
- Open Access
- 22 May 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Parvovirus B19-induced aplastic crises in children with hereditary spherocytosis in the Czech Republic: multicentre retrospective study
Hereditary spherocytosis is the most common congenital anaemia in Europe. In patients with this disease, parvovirus B19 infection leads to aplastic crisis
- 22 May 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessParvovirus B19-induced aplastic crises in children with hereditary spherocytosis in the Czech Republic: multicentre retrospective study
Hereditary spherocytosis is the most common congenital anaemia in Europe. In patients with this disease, parvovirus B19 infection leads to aplastic crisis
- Open Access
- 15 April 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (4) , e70249
Severe Hypertension and Hematologic Abnormalities in Pseudoxanthoma Elasticum: A Pediatric Case Report
Pseudoxanthoma elasticum (PXE) is a rare autosomal recessive disorder caused by pathogenic variants in ABCC6 , leading to progressive calcification of elastic fibers. Although PXE typically presents in adolescence with dermatologic or ocular manifestations, early vascular involvement, including pediatric hypertension, is increasingly recognized. We report a 3‐year‐old boy referred for evaluation of persistent erythrocytosis of unclear etiology. Clinical, biochemical, and hematologic assessments revealed intermittent reticulocytosis, normal oxygen saturation, and suppressed/normal erythropoietin levels. Long‐term zinc supplementation initiated in infancy for suspected dermatitis enteropathica preceded the onset of erythrocytosis. At age eight, severe systemic hypertension was diagnosed together with medullary nephrocalcinosis and splenic and pancreatic calcifications. Imaging excluded renal artery stenosis. Whole‐exome sequencing identified compound heterozygous pathogenic ABCC6 variants, establishing the diagnosis of PXE. Ophthalmologic examination revealed peau d'orange. Blood pressure control required combination antihypertensive therapy and was associated with partial normalization of red blood cell (RBC) parameters and a marked increase in plasma renin activity. RBC enzymatic profiling demonstrated metabolic adaptations consistent with oxidative stress. This case illustrates an unusual clinical presentation of PXE in early childhood. We propose that erythrocytosis, potentially promoted by zinc supplementation, may have contributed to early vascular stress and hypertension. Later, renal microvascular calcification and renin–angiotensin–aldosterone system activation may have contributed to the persistence of elevated RBC counts despite low erythropoietin. These observations suggest that PXE may be considered in the differential diagnosis of children with unexplained hypertension, particularly when additional systemic findings are present.
- 15 April 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (4) , e70249
Open AccessSevere Hypertension and Hematologic Abnormalities in Pseudoxanthoma Elasticum: A Pediatric Case Report
Pseudoxanthoma elasticum (PXE) is a rare autosomal recessive disorder caused by pathogenic variants in ABCC6 , leading to progressive calcification of elastic fibers. Although PXE typically presents in adolescence with dermatologic or ocular manifestations, early vascular involvement, including pediatric hypertension, is increasingly recognized. We report a 3‐year‐old boy referred for evaluation of persistent erythrocytosis of unclear etiology. Clinical, biochemical, and hematologic assessments revealed intermittent reticulocytosis, normal oxygen saturation, and suppressed/normal erythropoietin levels. Long‐term zinc supplementation initiated in infancy for suspected dermatitis enteropathica preceded the onset of erythrocytosis. At age eight, severe systemic hypertension was diagnosed together with medullary nephrocalcinosis and splenic and pancreatic calcifications. Imaging excluded renal artery stenosis. Whole‐exome sequencing identified compound heterozygous pathogenic ABCC6 variants, establishing the diagnosis of PXE. Ophthalmologic examination revealed peau d'orange. Blood pressure control required combination antihypertensive therapy and was associated with partial normalization of red blood cell (RBC) parameters and a marked increase in plasma renin activity. RBC enzymatic profiling demonstrated metabolic adaptations consistent with oxidative stress. This case illustrates an unusual clinical presentation of PXE in early childhood. We propose that erythrocytosis, potentially promoted by zinc supplementation, may have contributed to early vascular stress and hypertension. Later, renal microvascular calcification and renin–angiotensin–aldosterone system activation may have contributed to the persistence of elevated RBC counts despite low erythropoietin. These observations suggest that PXE may be considered in the differential diagnosis of children with unexplained hypertension, particularly when additional systemic findings are present.